)

iSpecimen (ISPC) investor relations material
iSpecimen SEO filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and business model
Operates a technology-driven global marketplace connecting researchers with human biospecimens and associated data, streamlining procurement for life science research and development.
Revenue is generated by sourcing specimens from a network of healthcare providers and distributing them to research clients, with a revenue-sharing model for suppliers.
The platform supports a wide range of biospecimen types, including biofluids, tissues, and hematopoietic stem and immune cells, sourced as remnant or research-use-only specimens.
The supply network spans 76 organizations across 11 countries, and the customer base includes biopharma, diagnostics, and government/academic institutions.
The company is also launching a Solana-based digital asset treasury program to diversify its balance sheet and support long-term growth.
Financial performance and metrics
For the six months ended June 30, 2025, revenue was $1.77M, down 66% from $5.15M in the prior year period, primarily due to a 57% decrease in specimen count and a change in revenue recognition.
Net loss for the six months ended June 30, 2025 was $2.71M, compared to $5.01M in the prior year period.
As of June 30, 2025, cash and cash equivalents were $589K, with a working capital deficit of $4.0M and an accumulated deficit of $74.6M.
Cost-cutting measures since 2023 have reduced monthly compensation costs by 146% and technology costs by 64% year-over-year.
The company has a history of recurring losses and negative cash flows, raising substantial doubt about its ability to continue as a going concern.
Use of proceeds and capital allocation
No proceeds will be received from the resale of shares by selling stockholders; any proceeds from warrant exercises (up to $129) will be used for working capital and general corporate purposes.
Recent capital raises include a $1.75M private placement in August 2025 and a $4M underwritten public offering in July 2025, with proceeds allocated to marketing, software, and working capital.
The company plans to raise up to $200M over 1-2 years for its Solana-based treasury program, with an initial $50M targeted in Q4 2025.
Next iSpecimen earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage